Document
IPR2017-01434, No. 1025-25 Exhibit - Exhibit 1025 US Patent No 3,914,265 to Middleton (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01434, No. 1025-25 Exhibit - Exhibit 1025 US Patent No 3,914,265 to Middleton (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01434, No. 1016-16 Exhibit - Exhibit 1016 Product Details for NDA 020597 XALATAN (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01434, No. 1016-16 Exhibit - Exhibit 1016 Product Details for NDA 020597 XALATAN (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01434, No. 1061-109 Exhibit - Exhibit 1061 US Patent No 4,599,353 to Bito LZ 1986 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2017-01434, No. 1061-109 Exhibit - Exhibit 1061 US Patent No 4,599,353 to Bito LZ 1986 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 1040-88 Exhibit - Camras CB et al, ¿¿¿Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six month, masked, multicenter trial in the Un...
Cite Document
IPR2017-01434, No. 1040-88 Exhibit - Camras CB et al, ¿¿¿Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six month, masked, multicenter trial in the United St
+ More Snippets
Document
IPR2017-01434, No. 1036-84 Exhibit - Alm A, ¿¿¿Latanoprost in the treatment of glaucoma,¿¿¿ Clin Ophthalmol, 81967¿¿¿85 2014 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2017-01434, No. 1036-84 Exhibit - Alm A, ¿¿¿Latanoprost in the treatment of glaucoma,¿¿¿ Clin Ophthalmol, 81967¿¿¿85 2014 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2040-70 Exhibit - Ex2040 Travatan Label (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2040-70 Exhibit - Ex2040 Travatan Label (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2036-66 Exhibit - Ex2036 Aung 2002 (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2036-66 Exhibit - Ex2036 Aung 2002 (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2056-111 Exhibit - Ex 2056 Human Metabolome Database tafluprost (P.T.A.B. Jul. 26, 2018)
Cite Document
IPR2017-01434, No. 2056-111 Exhibit - Ex 2056 Human Metabolome Database tafluprost (P.T.A.B. Jul. 26, 2018)
+ More Snippets
Document
IPR2017-01434, No. 1054-102 Exhibit - Santen Pharmaceutical Co, Ltd Data Book Year Ended March 31, 2016 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2017-01434, No. 1054-102 Exhibit - Santen Pharmaceutical Co, Ltd Data Book Year Ended March 31, 2016 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 1055-103 Exhibit - Exhibit 1055 GlobalData Healthcare 2018 (P.T.A.B. Jun. 5, 2018)
Cite Document
IPR2017-01434, No. 1055-103 Exhibit - Exhibit 1055 GlobalData Healthcare 2018 (P.T.A.B. Jun. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2037-67 Exhibit - Ex2037 Xalatan Label (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2037-67 Exhibit - Ex2037 Xalatan Label (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 2043-73 Exhibit - Ex2043 Iopidine Label (P.T.A.B. Mar. 5, 2018)
Cite Document
IPR2017-01434, No. 2043-73 Exhibit - Ex2043 Iopidine Label (P.T.A.B. Mar. 5, 2018)
+ More Snippets
Document
IPR2017-01434, No. 1030-52 Exhibit - Exhibit 1030 New Version of Exhibit 1007 with Certified Translation (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2017-01434, No. 1030-52 Exhibit - Exhibit 1030 New Version of Exhibit 1007 with Certified Translation (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2004-32 Exhibit - Ex 2004 Xalatan 1996 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2004-32 Exhibit - Ex 2004 Xalatan 1996 (P.T.A.B. Sep. 7, 2017)
+ More Snippets
Document
IPR2017-01434, No. 2019-47 Exhibit - Ex 2019 R Tech Ueno 2009 (P.T.A.B. Sep. 7, 2017)
Cite Document
IPR2017-01434, No. 2019-47 Exhibit - Ex 2019 R Tech Ueno 2009 (P.T.A.B. Sep. 7, 2017)
+ More Snippets